Atosiban
Specifications
90779-69-4CAS Number
806-815-5EC Number
(2S)-N-[(2S)-5-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-16-[(4-ethoxyphenyl)methyl]-10-[(1R)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-IUPAC Name
C43H67N11O12S2Chemical Formula
994.2 g/molMolecular Weight
Atosiban; 90779-69-4; Tractocile; Antocin; Antocin II; tractocil; Rwj 22164; Antocile; Atosibanum; ORF 22164; Orf-22164; RWJ-22164; DTXSID8048991; CAP-476; 1-Deamino-2D-tyr-(OEt)-4-thr-8-orn-oxytocin; RW-22164; CAP-449; CAP-581; 081D12SI0Z; F-314; (2S)-N-[(2S)-5-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-16-[(4-ethoxyphenyl)methyl]-10-[(1R)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide; DTXCID4028917; 1-(3-Mercaptopropionic acid)-2-(3-(p-ethoxyphenyl)-D-alanine)-4-L-threonine-8-L-ornithineoxytocin; Oxytocin, 1-(3-mercaptopropanoic acid)-2-(O-ethyl-D-tyrosine)-4-L-threonine-8-L-ornithine-; (2S)-N-((2S)-5-amino-1-((2-amino-2-oxoethyl)amino)-1-oxopentan-2-yl)-1-((4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-((2S)-butan-2-yl)-16-((4-ethoxyphenyl)methyl)-10-((1R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide; (2S)-N-((2S)-5-amino-1-((2-amino-2-oxoethyl)amino)-1-oxopentan-2-yl)-1-((4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-((2S)-butan-2-yl)-16-((4-ethoxyphenyl)methyl)-10-(1-hydroxyethyl)-6,9,12,15,18-pentaoxo1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide; (2S)-N-[(2S)-5-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-16-[(4-ethoxyphenyl)methyl]-10-(1-hydroxyethyl)-6,9,12,15,18-pentaoxo1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide; RefChem:115452; 1-deamino-2-Tyr(OEt)-4-Thr-8-Orn-oxytocin; (Mpa(1),D-Tyr(Et)2,Thr(4),Orn(8))oxytocin; (Mpa(1)-D-Tyr(Et)(2)-Thr(4)-Orn(8))-oxytocin; oxytocin, 1-deamino-(O-Et-Tyr)(2)-Thr(4)-Orn(8)-; G02CX01; oxytocin, 1-deamino-O-ethyltyrosyl(2)-threonyl(4)-ornithine(8)-; CHEMBL382301; (S)-N-((S)-5-Amino-1-((2-amino-2-oxoethyl)amino)-1-oxopentan-2-yl)-1-((4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-((S)-sec-butyl)-16-(4-ethoxybenzyl)-10-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide; dTVT; MFCD00672436; NCGC00165718-01; C43H67N11O12S2; Atosibanum [INN-Latin]; Atosiban [USAN:INN:BAN]; UNII-081D12SI0Z; Atosiban Aceta; Atosiban?; deTVT; ATOSIBAN [USAN]; ATOSIBAN [INN]; ATOSIBAN [MI]; ATOSIBAN [MART.]; ATOSIBAN [WHO-DD]; SCHEMBL34316; d[D-Tyr(Et)2,Thr4]OVT; ChEMBL_332615; GTPL2213; orb1223687; orb1689940; Atosiban, >=98% (HPLC); EX-A7437A; CAP-440; CHEBI:135899; VWXRQYYUEIYXCZ-OBIMUBPZSA-N; ORF22164; Tox21_113474; BDBM50177595; d[D-Tyr(Et)2,Thr4,Orn8]vasotocin; AKOS015994643; CCG-270604; DB09059; HS-2003; RW22164;RWJ22164; NCGC00165718-02; BP-50419; DA-59548; SY301205; CAS-90779-69-4; C77085; (Deamino-Cys1,D-Tyr(Et)2,Thr4,Orn8)-Oxytocin acetate salt; (2S)-5-amino-2-{[(2S)-1-{[(4R,7S,10S,13S,16R)-13-[(2S)-butan-2-yl]-7-(carbamoylmethyl)-16-[(4-ethoxyphenyl)methyl]-10-[(1R)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}pyrrolidin-2-yl]formamido}-N-(carbamoylmethyl)pentanamide; (2S)-N-[(1S)-4-amino-1-[(2-amino-2-oxo-ethyl)carbamoyl]butyl]-1-[(4R,7S,10S,13S,16R)-7-(2-amino-2-oxo-ethyl)-16-[(4-ethoxyphenyl)methyl]-10-[(1R)-1-hydroxyethyl]-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide; (S)-N-[(S)-5-Amino-1-[(2-amino-2-oxoethyl)amino]-1-oxo-2-pentyl]-1-[(4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-[(S)-sec-butyl]-16-(4-ethoxybenzyl)-10-[(R)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide; 1-{(4R,7S,10S,13S,16R)-7-(2-Amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-16-[(4-ethoxyphenyl)methyl]-10-[(1R)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl}-L-prolyl-L-ornithylglycinamide; Glycinamide, O-ethyl-N-(3-mercapto-1-oxopropyl)-D-tyrosyl-L-isoleucyl-L-threonyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-ornithyl-, cyclic (1-->5)-disulfide; GLYCINAMIDE, O-ETHYL-N-(3-MERCAPTO-1-OXOPROPYL)-D-TYROSYL-L-ISOLEUCYL-L-THREONYL-L-ASPARAGINYL-L-CYSTEINYL-L-PROLYL-L-ORNITHYL-, CYCLIC (1->5)-DISULFIDESynonyms
Products Containing Atosiban
Atosiban SUN 6,75 mg/0,9 ml solucion inyectable EFGAtosiban SUN 37,5 mg/5 ml concentrado para solucion para perfusion EFGTRACTOCILE 7,5 mg/ml, SOLUCION INYECTABLETRACTOCILE 7,5 mg/ml, CONCENTRADO PARA SOLUCION PARA PERFUSIONAtosiban Pharmidea 37.5mg/5mlAtosiban Pharmidea 6,75mg/0,9mlTractocileBetosibanBetosibanAtosiban EVER Pharma 37,5 mg/5 mlGENTROCIL 37.5mg/5mlAtosiban EVER Pharma 6,75mg/0,9ml
Page 1 of 3
Services Offering Atosiban
Companies Selling Atosiban
HR
Hangzhou Royall Import & Export Co.,LtdChinaHD
Hangzhou Dingyan Chem Co., LtdChinaQC
QYAOBIO(ChinaPeptides co., Ltd.)ChinaPage 1 of 3